Clinical Trials Browser

Phase 3 × Active not recruiting × Cutaneous Squamous Cell Carcinoma × Clear all

NCT03969004 2026-03-27

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Phase 3 Active not recruiting

415 enrolled 1 FDA

Cutaneous Squamous Cell Carcinoma